2021 Silver Medal Award

The group is honored for advancing the state-of-the-art in methods for determining the higher-order protein structure of biotherapeutics. The group led two technically challenging international comparison studies, establishing the reproducibility and limitations of novel precision measurement methods. Additionally, they developed new data acquisition and analysis tools and new hardware to address method limitations that have hastened broad industry adoption and provide a foundation for measurements that ensure quality and accelerate development of life-saving biotherapeutics and biosimilars.